References
- 1. Turner NC, Dusheiko G and Jones A. Hepatitis C and B-cell lymphoma. Ann Oncol 2003;14:1341-134510.1093/annonc/mdg36312954572
- 2. Zignego AL, Gianinni C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 2007;13(17):2467-2475.10.3748/wjg.v13.i17.2467414676617552031
- 3. Vlădăreanu A-M. Limfoamele în corelaţie cu virusurile limfotrope. Editura Amaltea 2007.Cap. Limfoamele maligne şi virusurile hepatitice. Pag. 63-93
- 4. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G et al. Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol. 1994;88(2):392-394.10.1111/j.1365-2141.1994.tb05036.x7803287
- 5. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 1994 Nov 1;84(9):3047-53.10.1182/blood.V84.9.3047.bloodjournal8493047
- 6. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al. Hepatitis C virus and B-cell non- Hodgkin lymphomas: an italian multicenter case- control study. Blood. 2003;102(3):996-999.10.1182/blood-2002-10-323012714514
- 7. Duberg A-S, Nordstrom M, Torner A, Reichard O, Strauss R, Janson R et al. Non-Hodgkin’s lymphoma and other neoplastic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;41(3):652-659.10.1002/hep.2060815723449
- 8. Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev.2008;17(11):3069-75.10.1158/1055-9965.EPI-08-0408259745318957521
- 9. Del Masso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev.2006;15(11):2078-2085.10.1158/1055-9965.EPI-06-030817119031
- 10. Imai Y, Oshawa M, Tanaka H. High prevalence of HCV infection in patients with B-cell non-Hodgkin’s lymphoma: comparison with birth cohort-and sex-matched blood donors in a Japanese population. Hepatology. 2002;35:974-6.10.1053/jhep.2002.3214911915049
- 11. Al-Ghiti AAO, Arbanas T, Diculescu M. Epidemiological characteristics of hepatitis C and B viral infection in patients with lymphoproliferations sustain their role in lymphomagenesis. Medica. 2006;4(1):5-11.
- 12. Yenice N, Gulluk F, Arican N, Turkmen S. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol 2003;14(3):173-176.
- 13. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K et al. Prevalence of hepatitis B or C virus infection in patients with non-Hodgkin’s lymphoma. J Gastroenterol Hepatol 2001;16(2):215-9.10.1046/j.1440-1746.2001.02406.x11207904
- 14. Kang J, Cho JH, Suh SW, Lee DH, Oh HB, Sohn YH et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011;90(2):159-64.10.1007/s00277-010-1055-5
- 15. De Rosa G, Gabbo ML, De Renzo A. High prevalence of hepatitis C virus infections in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997;55:77-82.10.1002/(SICI)1096-8652(199706)55:2<77::AID-AJH5>3.0.CO;2-#
- 16. Zucca E, Roggero E, Maggi-Solca N, Conconi A, Bertoni F, Reilly I et al. Prevalence of Helicobacter Pylori and hepatitis C virus infections among non-Hodgkin’s lymphoma patients in Southern Switzerland. Haematologica 2000;85:147-153.
- 17. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute- Working Group 1996 guidelines. Blood. 2008 Jun 15;111(12):5446-56.10.1182/blood-2007-06-093906
- 18. Mowery YM, Lanasa MC. Clinical aspects of monoclonal B-cell lymphocytosis. Cancer Control. 2012 Jan;19(1):8-17.10.1177/107327481201900102
- 19. Ghia P. Another piece in the puzzle: is there a “nodal” monoclonal B-cell lymphocytosis? Haematologica 2011;96(8):1089-1091.
- 20. Matos DM, Falcão RP. Monoclonal B-cell lymphocytosis: a brief review for general clinicians. Sao Paulo Med J. 2011 May;129(3):171-5.10.1590/S1516-31802011000300008
- 21. Marti G E, Rawstron A C, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325-332.10.1111/j.1365-2141.2005.05550.x
- 22. Rawstron A C, Green M J, Kuzmicki A, Kennedy B, Fenton JA, Evans PA et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635-639.
- 23. Ohtsubo K, Sata M, Kawaguchi T, Morishige S, Takata Y, Oku E, Imamura R et al. Characterisation of the light chain-restricted clonal B cells in peripheral blood of HCV- positive patients. Int J Hematol 2009;89(4):452-459.10.1007/s12185-009-0301-x
- 24. Johansson P, De Dechene E M, Eisele L, Kieruzel S, Horn P, Schmucker U et al. Increased prevalence of monoclonal B lymphocytosis in patients with chronic hepatitis C. Journal of Hepatology 2010;52(1):274.10.1016/S0168-8278(10)60707-6
- 25. Fazi C, Dagklis A, Cottini F, Scarfo L, Bertilaccio MT, Finazzi R et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom 2010;78(1):61-8.10.1002/cyto.b.20545